4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-006123
10% owner sold 100,000 shares at an average $35.78 ($3,578,103)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morningside Venture Investments Ltd 10% owner | 2023-02-22 | Sale | −39,916 | $35.91 | $1,433,384 | 7,640,682 | D |
| Morningside Venture Investments Ltd 10% owner | 2023-02-22 | Sale | −10,084 | $36.34 | $366,453 | 7,630,598 | D |
| Morningside Venture Investments Ltd 10% owner | 2023-02-23 | Sale | −48,889 | $35.55 | $1,738,004 | 7,581,709 | D |
| Morningside Venture Investments Ltd 10% owner | 2023-02-23 | Sale | −1,111 | $36.24 | $40,263 | 7,580,598 | D |
| Open-market sales · 100,000 sh · avg $35.78 · $3,578,103 | |||||||
Loading xslF345X03/doc4.xml…